Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Radiologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Key statistics for lung cancer. In: American cancer society.(Available at:) (Accessed January 15, 2022)
- Outcomes of older patients with pulmonary fibrosis and non-small cell lung cancer.Ann Am Thorac Soc. 2019; 16: 1034-1040
- Thoracoscopic lobectomy: the gold standard for early-stage lung cancer?.Ann Thorac Surg. 2010; 89: S2098-S2101
- Idiopathic pulmonary fibrosis and lung cancer. a systematic review and meta-analysis.Ann Am Thorac Soc. 2019; 16: 1041-1051
- Clinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis.J Thorac Dis. 2016; 8: 977-984
- Lung cancer and interstitial lung disease: a literature review.J Thorac Dis. 2018; 10: 3829-3844
- Prevalence of lung cancer in patients with interstitial lung disease is higher than in those with chronic obstructive pulmonary disease.Medicine (Baltimore). 2018; 97: e0071
- Impact of idiopathic pulmonary fibrosis on recurrence after surgical treatment for stage I–III non-small cell lung cancer.PLoS One. 2020; 15: e0235126
- Clinicopathological, immunohistochemical, and genetic features of primary lung adenocarcinoma occurring in the setting of usual interstitial pneumonia pattern.J Thorac Oncol. 2016; 11: 2141-2149
- Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data.Respir Res. 2018; 19: 195
- Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients.Sci Rep. 2021; 11: 8312
- Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study.Respir Res. 2019; 20: 117
- Cumulative incidence of and predictive factors for lung cancer in IPF.Respirology. 2009; 14: 723-728
- Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival.Thorac Cancer. 2020; 11: 1911-1917
- Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases.J Thorac Cardiovasc Surg. 2015; 149 (70.e1-2): 64-69
- Evaluation and management of lung cancer in patients with interstitial lung disease.in: King T. UpToDate. 2021 (Available at:) (Accessed September 12, 2021)
- Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians.Ther Adv Respir Dis. 2021; 15 (17534666211039772)
- Patients with IPF and lung cancer: diagnosis and management.Lancet Respir Med. 2018; 6: 86-88
- Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis: Idiopathic pulmonary fibrosis with lung cancer.Thorac Cancer. 2012; 3: 150-155
- High-resolution CT of complications of idiopathic fibrotic lung disease.Br J Radiol. 2011; 84: 581-592https://doi.org/10.1259/bjr/65090500
- Evolving early lung cancers detected during follow-up of idiopathic interstitial pneumonia: serial CT features.AJR Am J Roentgenol. 2015; 204: 1190-1196https://doi.org/10.2214/AJR.14.13587
- Incremental value of PET/CT over ct for mediastinal nodal staging of non–small cell lung cancer: comparison between patients with and without idiopathic pulmonary fibrosis.Am J Roentgenol. 2010; 195: 370-376
- Image-guided percutaneous lung needle biopsy: how we do it.Tech Vasc Interv Radiol. 2021; 24: 100770
- Safety and success of repeat lung needle biopsies in patients with epidermal growth factor receptor-mutant lung cancer.Oncologist. 2019; 24: 1570-1576
- Accuracy and complications of percutaneous transthoracic needle lung biopsy for the diagnosis of malignancy in patients with idiopathic pulmonary fibrosis.Eur Radiol. 2021; 31: 9000-9011
- Overview of interventional pulmonology for radiologists.RadioGraphics. 2021; 41: 1916-1935
- Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial.Lancet Respir Med. 2015; 3: 282-289
- Diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules: a systematic review and meta-analysis.Respir Int Rev Thorac Dis. 2014; 87: 165-176
- Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis.J Surg Oncol. 2002; 81: 33-37
- Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.J Thorac Cardiovasc Surg. 2014; 147: 1604-1611.e3
- Preoperative CT findings for predicting acute exacerbation of interstitial pneumonia after lung cancer surgery: a multicenter case-control study.Am J Roentgenol. 2021; 217: 859-869
- Clinical analysis of interstitial pneumonia after surgery for lung cancer.Jpn J Thorac Cardiovasc Surg. 2004; 52: 323-329
- Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?.J Thorac Cardiovasc Surg. 2008; 136: 1357-1363.e1-2
- Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.Ann Thorac Surg. 2016; 102: 1905-1910
- Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review.Int J Radiat Oncol. 2017; 98: 622-631
- Non-small cell lung cancer (Version 1.2022).(Available at:) (Accessed February 18, 2022)
- Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival in patients treated with lung stereotactic body radiation therapy (SBRT).Clin Lung Cancer. 2018; 19: e219-e226
- stereotactic body radiation therapy for patients with pulmonary interstitial change: high incidence of fatal radiation pneumonitis in a retrospective multi-institutional study.Cancers. 2018; 10: 257
- Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.Br J Radiol. 2017; 90: 20160508
- The Use of Proton Therapy in the Treatment of Lung Cancers.Cancer J. 2014; 20: 427-432
- Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy.Radiat Oncol. 2019; 14: 19
- The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.Radiat Oncol. 2016; 11: 56
- Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy.Radiat Oncol. 2021; 16: 70
- Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer.Radiat Oncol Lond Engl. 2014; 9: 74https://doi.org/10.1186/1748-717X-9-74
- Update on Image-Guided Thermal Lung Ablation: Society Guidelines, Therapeutic Alternatives, and Postablation Imaging Findings.AJR Am J Radiol. 2022; : 1-15https://doi.org/10.2214/AJR.21.27099
- thermal ablation matches sublobar resection outcomes in older patients with early-stage non–small cell lung cancer.J Vasc Interv Radiol. 2014; 25: 1-9.e1
- Comparison of survival after sublobar resections and ablative therapies for stage I non−small cell lung cancer.J Am Coll Surg. 2010; 211: 68-72
- Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center’s experiences.Am J Roentgenol. 2011; 197: W576-W580
- Efficacy and safety of thermal ablation of lung malignancies: A Network meta-analysis.Ann Thorac Med. 2018; 13: 243-250
- OA12.03 Percutaneous cryoablation for lung cancer patients for whom surgery or radiotherapy is contraindicated due to idiopathic pulmonary fibrosis.J Thorac Oncol. 2017; 12: S290
- the risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer.J Thorac Oncol. 2011; 6: 1242-1246https://doi.org/10.1097/JTO.0b013e318216ee6b
- Predictive value of 18F-FDG PET/CT for acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease treated with chemotherapy.Int J Clin Oncol. 2020; 25: 681-690
- Impact of interstitial lung disease classification on the development of acute exacerbation of interstitial lung disease and prognosis in patients with stage iii non-small-cell lung cancer and interstitial lung disease treated with chemoradiotherapy.J Cancer. 2018; 9: 2054-2060
- A primer on interstitial lung disease and thoracic radiation.J Thorac Oncol. 2020; 15: 902-913
- immune checkpoint inhibitor cancer therapy: spectrum of imaging findings.Radiogr Rev Publ Radiol Soc N Am Inc. 2017; 37: 2132-2144
- Risk of pneumonitis and pneumonia associated with immune checkpoint inhibitors for solid tumors: a systematic review and meta-analysis.Front Immunol. 2019; 10: 108
- Outcomes of patients with interstitial lung disease receiving programmed cell death 1 inhibitors: a retrospective case series.Clin Lung Cancer. 2021; 22: e738-e744
- Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.N Engl J Med. 2014; 370: 2071-2082
Article info
Publication history
Published online: September 02, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
